期刊文献+

脂联素及其受体在肝细胞性肝癌组织中的表达 被引量:1

Expression of adiponectin and its receptors in human hepatocellular carcinoma tissues
原文传递
导出
摘要 目的 探讨脂联素及其受体——脂联素受体1(AdipoR1)、脂联素受体2(AdipoR2)和T-钙黏蛋白(T-cadherin)的表达与肝细胞性肝癌(HCC)临床病理特征的关系.方法 免疫组织化学法检测脂联素及其受体在42例HCC交界组织(含癌组织及癌旁组织)的表达.结果 脂联素(2.88±1.06比5.98 ±0.95)、AdipoR1(2.36±1.38比5.43±1.04)、AdipoR2(2.29±1.55比5.14±1.22)及T-cadherin(2.17±1.34比5.21±1.18)在HCC癌组织中的表达低于癌旁组织,且在伴有癌栓的癌组织中表达亦显著降低.脂联素(2.30±1.16比3.06 ±0.98)、AdipoR2(1.20±1.48比2.63±1.43)在伴卫星灶的癌组织表达低于不伴卫星灶的癌组织;直径>5 cm的癌组织中T-cadherin表达(1.59±1.33)低于直径≤5 cm的癌组织(2.56±1.23).结论 脂联素及其受体表达下调可能在HCC肝内转移过程中起一定作用. Objective To investigate the relationship among adiponectin,its receptors (AdipoR1,AdipoR2 and T-cadherin) and the pathological characteristics of human hepatocellular carcinoma (HCC).Methods The expression of Adiponectin,AdipoRl,AdipoR2 and T-cadherin was detected by immunohistochemistry in 42 cases of HCC tissues (tumor hepatic tissues and pericarcinomatous tissues).Results The expression of Adiponectin (2.88 ± 1.06 vs.5.98 ± 0.95),AdipoR1 (2.36 ± 1.38 vs.5.43 ±1.04),AdipoR2 (2.29±1.55 vs.5.14±1.22) andT-cadherin (2.17±1.34 vs.5.21 ±1.18) was decreased in tumor hepatic tissues compared to pericarcinomatous tissues.The expression of Adiponectin (2.57±1.03 vs.3.19±1.03),AdipoR1 (1.81 ±1.44 vs.2.90±1.09),AdipoR2 (1.48±1.47 vs.3.10 ± 1.18) and T-cadherin (1.76 ± 1.34 vs.2.57 ± 1.25) in HCC tissues with tumor thrombi was lower than in cancerous tissues without tumor thrombi.Adiponectin (2.30 ± 1.16 vs.3.06 ±0.98) and AdipoR2 (1.20 ± 1.48 vs.2.63 ± 1.43) expression in HCC tissues with satellite lesions was lower than in cancerous tissues without satellite lesions.The expression of T-cadherin in large size (〉5 cm) tumor tissues (1.59 ± 1.33) was lower than in the small size (≤5 cm) tumor tissues (2.56 ± 1.23).Conclusion The decreased expression of Adiponectin and its receptors may play a role in the intrahepatic metastasis of HCC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第12期2843-2845,F0004,共4页 Chinese Journal of Experimental Surgery
关键词 肝细胞 脂联素 Carcinoma,hepatocellular Adiponectin
  • 相关文献

参考文献13

  • 1Bhaskaran K,Douglas I,Forbes H,et al.Body-mass index and risk of 22 specific cancers:a population-based cohort study of 5.24 million UK adults[J].Lancet,2014,384(9945):755-765.
  • 2Barb D,Williams CJ,Neuwirth AK,et al.Adiponectin in relation to malignancies:a review of existing basic research and clinical evidence[J].Am J Clin Nutr,2007,86(3):s858-s866.
  • 3Yamauchi T,Kamon J,Ito Y,et al.Cloning of adiponectin receptors that mediate antidiabetic metabolic effects[.J].Nature,2003,423(6941):762-769.
  • 4Vestal D J,Ranscht B.Glycosyl phosphatidylinositol--anchored T-cadherin mediates calcium-dependent,homophilic cell adhesion[J].J Cell Biol,1992,119(2):451-461.
  • 5Hug C,Wang J,Ahmad NS,et al.T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin[J].Proc Natl Acad Sci U S A,2004,101(28):10308-10313.
  • 6Philippova M,lvanov D,Tkachuk V,et al.Polarisation of T-cadherin to the leading edge of migrating vascular cells in vitro:a function in vascular cell motility[J].Histochem Cell Biol,2003,120(5):353-360.
  • 7Mohamed EE,Mohammed MH,Enaase AM,et al.Circulating adiponectin:a potential prognostic marker for hepatocellular carcinoma[J].Chinese-Gerran J Clin Oncol,2011,10(10):570-574.
  • 8Kotani K,Wakai K,Shibata A,et al.Serum adiponectin multimer complexes and liver cancer risk in a large cohort study in Japan[J].Asian Pac J Cancer Prey,2009,10 Suppl:87-90.
  • 9Shin E,Yu YD,Kim DS,et al.Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma[J].Pathol Oncol Res,2014,20(3):667-675.
  • 10Brakenhielm E,Veitonmaki N,Cao R,et al.Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis[J].Proc Natl Acad Sci U S A,2004,101(8):2476-2481.

二级参考文献8

  • 1Takeichi 5I. Cadherin cell adhesion receptors as a morphogenetic regulator. Science,1991,251:1451-1455.
  • 2Levenberg S, Yarden A, Kam Z, et al. p27 is involved in N-eadherin mediated contact inhibition of cell growth and S-phase entry. Oncogene, 1999,18:869-876.
  • 3Sato M,Mori Y,Sakurada A,et al. The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet, 1998,103:96-101.
  • 4Sakai M, Hibi K, Koshikawa K, et al. Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer. Cancer Sci ,2004, 95:588-591.
  • 5Fiegl H, Millinger S, Goebel G, et al. Breast cancer DNA methylation profiles in callcer cells and tumor stroma:association with HER-2/neu status in primary breast cancer. Cancer Res,2006 ,66 :29-33.
  • 6Ulivi P,Zoli W,Calistri D,et al. p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients. J Cell Physical, 2006,206 : 611-615.
  • 7Harper JW,Adami GR,Wei N,et al.The p21 cdk-interacting protein Cip1 is a potent inhibitor od G1 cyclin-dependent kinase.Cell,1993,75:805-816.
  • 8El-Deriy WS,Tokino T,Velculescu VE,et al.WAF1,a potential mediator of p53 tumor suppression.Cell,1993,75:817-825.

共引文献7

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部